Literature DB >> 16104381

Genetic and phenotypic analysis of Tcm, a mutation affecting early eye development.

Ken S Wang1, Lauren E Zahn, Jack Favor, Kristen M Huang, Dwight Stambolian.   

Abstract

Tcm (total cataract with microphthalmia) is an autosomal dominant mouse eye mutation. Heterozygous Tcm/+ mice are born with several eye malformations including microphthalmia, retinal and iris dysplasia, total lens cataract, and ventral coloboma. The Tcm mutation was previously mapped to a 26-Mb region on Chr 4 between D4Mit235 and D4Mit106. In this study, we characterize the Tcm/ Tcm homozygous mutant and find they are viable but severely microphthalmic. The developing eye in the Tcm/Tcm homozygote shows defects during early eye development, before formation of the optic cup. Further genetic mapping reduced the Tcm critical region to a 1.3-Mb region bordered by SNPs rs3666764 and rs3713818. This critical region contains two known genes (Asph and Gfd6) and three predicted genes, all of which are positional candidates for Tcm. Sequence analysis of Tcm genomic DNA revealed no mutations in the coding regions and splice site junctions of the five candidate genes. These results indicate that the causitive Tcm mutation falls within a noncoding regulatory region of one of the five candidate genes or in an undescribed gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16104381     DOI: 10.1007/s00335-004-2444-7

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  42 in total

1.  Map Manager QTX, cross-platform software for genetic mapping.

Authors:  K F Manly; R H Cudmore; J M Meer
Journal:  Mamm Genome       Date:  2001-12       Impact factor: 2.957

2.  Human microphthalmia associated with mutations in the retinal homeobox gene CHX10. Percin EF, Ploder LA, Yu JJ, Arici K, Horsford DJ, Rutherford A, Bapat B, Cox DW, Duncan AMV, Kalnins VI, Kocak-Altintas A, Sowden JC, Trabousli E, Sarfarazi M, McInnes RR.*(1) Nat Gen 2000;25:397-401.

Authors: 
Journal:  Am J Ophthalmol       Date:  2001-01       Impact factor: 5.258

3.  Mutation of the gene encoding cellular retinaldehyde-binding protein in autosomal recessive retinitis pigmentosa.

Authors:  M A Maw; B Kennedy; A Knight; R Bridges; K E Roth; E J Mani; J K Mukkadan; D Nancarrow; J W Crabb; M J Denton
Journal:  Nat Genet       Date:  1997-10       Impact factor: 38.330

4.  Genomic, transcriptional and mutational analysis of the mouse microphthalmia locus.

Authors:  J H Hallsson; J Favor; C Hodgkinson; T Glaser; M L Lamoreux; R Magnúsdóttir; G J Gunnarsson; H O Sweet; N G Copeland; N A Jenkins; E Steingrímsson
Journal:  Genetics       Date:  2000-05       Impact factor: 4.562

5.  Aspartyl beta -hydroxylase (Asph) and an evolutionarily conserved isoform of Asph missing the catalytic domain share exons with junctin.

Authors:  J E Dinchuk; N L Henderson; T C Burn; R Huber; S P Ho; J Link; K T O'Neil; R J Focht; M S Scully; J M Hollis; G F Hollis; P A Friedman
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

6.  Recessive mutations in the RLBP1 gene encoding cellular retinaldehyde-binding protein in a form of retinitis punctata albescens.

Authors:  H Morimura; E L Berson; T P Dryja
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-04       Impact factor: 4.799

7.  Absence of post-translational aspartyl beta-hydroxylation of epidermal growth factor domains in mice leads to developmental defects and an increased incidence of intestinal neoplasia.

Authors:  Joseph E Dinchuk; Richard J Focht; Jennifer A Kelley; Nancy L Henderson; Nina I Zolotarjova; Richard Wynn; Nicola T Neff; John Link; Reid M Huber; Timothy C Burn; Mark J Rupar; Mark R Cunningham; Bernard H Selling; Jianhong Ma; Andrew A Stern; Gregory F Hollis; Robert B Stein; Paul A Friedman
Journal:  J Biol Chem       Date:  2001-12-31       Impact factor: 5.157

8.  Changing patterns of the retinoic acid system in the developing retina.

Authors:  P McCaffrery; K C Posch; J L Napoli; L Gudas; U C Dräger
Journal:  Dev Biol       Date:  1993-08       Impact factor: 3.582

9.  Ligand specificity in the CRAL-TRIO protein family.

Authors:  Candace Panagabko; Samantha Morley; Marta Hernandez; Patrick Cassolato; Heather Gordon; Rachel Parsons; Danny Manor; Jeffrey Atkinson
Journal:  Biochemistry       Date:  2003-06-03       Impact factor: 3.162

10.  PAX6 gene dosage effect in a family with congenital cataracts, aniridia, anophthalmia and central nervous system defects.

Authors:  T Glaser; L Jepeal; J G Edwards; S R Young; J Favor; R L Maas
Journal:  Nat Genet       Date:  1994-08       Impact factor: 38.330

View more
  3 in total

1.  Genetic polymorphisms of metabolic enzymes and the pharmacokinetics of indapamide in Taiwanese subjects.

Authors:  Teng-Hsu Wang; Cheng-Huei Hsiong; Hsin-Tien Ho; Tung-Yuan Shih; San-Jan Yen; Hui-Hung Wang; Jer-Yuarn Wu; Benjamin Pei-Chung Kuo; Yuan-Tsong Chen; Shung-Tai Ho; Oliver Yoa-Pu Hu
Journal:  AAPS J       Date:  2013-12-20       Impact factor: 4.009

2.  GDF6, a novel locus for a spectrum of ocular developmental anomalies.

Authors:  Mika Asai-Coakwell; Curtis R French; Karyn M Berry; Ming Ye; Ron Koss; Martin Somerville; Rosemary Mueller; Veronica van Heyningen; Andrew J Waskiewicz; Ordan J Lehmann
Journal:  Am J Hum Genet       Date:  2006-12-29       Impact factor: 11.025

3.  A γA-Crystallin Mouse Mutant Secc with Small Eye, Cataract and Closed Eyelid.

Authors:  Man Hei Cheng; Chung Nga Tam; Kwong Wai Choy; Wai Hung Tsang; Sze Lan Tsang; Chi Pui Pang; You Qiang Song; Mai Har Sham
Journal:  PLoS One       Date:  2016-08-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.